XML 19 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of the Business - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Candidate
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of novel therapeutic oncology candidates 6
Unrestricted cash and cash equivalents and available-for-sale securities $ 153.7